Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest announcement is out from Neuroscientific Biopharmaceuticals Ltd. ( (AU:NSB) ).
NeuroScientific Biopharmaceuticals Ltd has announced its upcoming Annual General Meeting, scheduled for November 12, 2025, in Perth, Australia. The meeting will cover the company’s annual report and include resolutions on the remuneration report and the election of directors, Robert McKenzie and Paul Fry. This meeting is significant for shareholders as it addresses key governance issues and provides an opportunity to influence the company’s strategic direction.
More about Neuroscientific Biopharmaceuticals Ltd.
NeuroScientific Biopharmaceuticals Ltd operates in the biopharmaceutical industry, focusing on the development of novel therapeutics targeting neurological disorders. The company is engaged in research and development of innovative drugs aimed at treating conditions such as Alzheimer’s disease and other neurodegenerative diseases.
Average Trading Volume: 575,962
Technical Sentiment Signal: Buy
Current Market Cap: A$54.87M
Find detailed analytics on NSB stock on TipRanks’ Stock Analysis page.